LINDSEY SCHUTTE: Open Payments
NPI 1588164107 · DAKOTA DUNES, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 31 payments from 13 companies in 2025. Trend: 2023 $490 · 2024 $440 · 2025 $579
Food & beverage: $579
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $141 |
| Novo Nordisk Inc | 8 | $133 |
| PFIZER INC. | 3 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| Astellas Pharma US Inc | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $17 |
Products named: QULIPTA, Ozempic, UBRELVY, CAPLYTA, Kerendia, ELIQUIS, Veozah, Wegovy.
Industry payments across SD — which companies pay providers there.
